This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Sano Chemicals, Texas A&M University System. Active years: 2024.
Company Filing History:
1 out of 1 
1 out of 1,326 Years Active: 2024
Title: The Innovative Contributions of Ravi Orugunty
Introduction
Ravi Orugunty is a notable inventor based in Round Rock, Texas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating fungal infections. His work is characterized by a focus on improving the pharmacological properties of existing compounds.
Latest Patents
Ravi Orugunty holds a patent for the "Synthesis of novel xylose free occidiofungin analogues and methods of using them." This invention pertains to methods for producing occidiofungin analogues that lack xylose, known as OF-Δxyl analogues. These analogues can incorporate various functional groups such as aldehyde, amine, triazole, or hydrazones. The OF-Δxyl analogues exhibit reduced inflammation and toxicity, along with superior pharmacological properties compared to natural occidiofungins. The invention provides methods for treating or preventing fungal infections by administering these analogues to subjects in need.
Career Highlights
Throughout his career, Ravi Orugunty has worked with reputable organizations, including the Texas A&M University System and Sano Chemicals. His experience in these institutions has contributed to his expertise in the field of pharmaceutical innovations.
Collaborations
Ravi has collaborated with notable colleagues such as James Leif Smith and Mengxin Geng. These partnerships have likely enhanced his research and development efforts in creating effective pharmaceutical solutions.
Conclusion
Ravi Orugunty's innovative work in synthesizing novel occidiofungin analogues demonstrates his commitment to advancing medical science. His contributions are vital in the ongoing fight against fungal infections, showcasing the importance of innovation in healthcare.